TearLab Corporation announced it has entered into a definitive agreement pursuant to which Accelmed Partners II (AP-II) will acquire TearLab. As part of the transaction, Dr. Uri Geiger will become Chairman of the Board and Accelmed Partners’ General Partner, Lior Shav, who led the transaction, will join the company’s board of directors. Seph Jensen, TearLab’s CEO, will remain a board member.